In a welcome move, Dun & Bradstreet saw its Relative Strength Rating rise from 63 to 74 on Tuesday.
IBD's unique rating tracks market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the trailing 52 weeks stacks up against all the other stocks in our database.
History reveals that the top-performing stocks often have an RS Rating north of 80 as they begin their biggest price moves. See if Dun & Bradstreet can continue to show renewed price strength and hit that benchmark.
Can You Really Time The Stock Market?
Dun & Bradstreet is working on a consolidation with a 12.95 entry. See if the stock can break out in volume at least 40% higher than normal.
Dun & Bradstreet reported 0% earnings growth in the latest quarterly report. Sales increased 4%. Keep an eye out for the company's next round of numbers on or around Feb. 13.
Dun & Bradstreet earns the No. 10 rank among its peers in the Commercial Services-Market Research industry group. Moody's, S&P Global and Gartner Inc are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
